RxDoctor Payments Data

Cecilia Nwakpuda, APRN

Family · Tucson, AZNPI 1922633718

Payments from drug & device makers

$254in general payments, 2019–2025

Across 15 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$66
  • Bard Peripheral Vascular, Inc.$27
  • Sanofi-aventis U.S. LLC$26
  • Novo Nordisk$24
  • Gilead$19
  • Johnson & Johnson$19
  • plus $73 from 5 others

What the payments were for

  • Food & beverage$254100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$254 in reported general payments places this provider in the 40th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$278
Medicare patients
12
Services billed
15

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide28$30,895
EliquisApixaban39$30,834
FarxigaDapagliflozin Propanediol30$29,066
OzempicSemaglutide19$23,804
JanuviaSitagliptin Phosphate12$16,420
MounjaroTirzepatide11$12,533
TradjentaLinagliptin19$5,354
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,232
Albuterol Sulfate HfaAlbuterol Sulfate112$2,085
Levemir FlexpenInsulin Detemir17$1,981
Atorvastatin Calcium191$1,670
Gabapentin81$1,373
Levothyroxine Sodium139$1,160
Omeprazole74$1,132
Famotidine60$937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$24$23,80419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 4,119 family providers in Arizona.

Other family in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →